Lam Research Corporation (LRCX) continues to make significant headway in the market with its consistent financial performance, beating quarter 4 projections with rising Y/Y revenues
regardless of high market expectations. Seizing the potentials of the
AI revolution, LRCX has introduced Lam Cryo™ 3.0, a pioneering Cryogenic Etch Technology. This innovative leap positions them as a significant player in advancing 3D NAND scaling, which is critical for future AI applications. Despite variations in stock performance, LRCX reported a strong outlook and recovery potential from several analysts. The company's $10 billion share repurchase authorization along with a 10-for-1 stock split announcement stirred more investor interest. Caution arises from
China risks that could balance out any gains from the memory recovery and AI boost, and some executive insider sells. However, many analysts maintain their positive outlook, including a price target increase to $1,050 by TD Cowen, overriding the fears ignited by the downgrade by other analysts.
Lam Research Corp LRCX News Analytics from Wed, 24 Jan 2024 08:00:00 GMT to Sun, 04 Aug 2024 06:45:02 GMT -
Rating 7
- Innovation 8
- Information 7
- Rumor 6
